These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10802771)

  • 1. Acute encephalopathy associated with vigabatrin in a six-month-old girl.
    Haas-Lude K; Wolff M; Riethmüller J; Niemann G; Krägeloh-Mann I
    Epilepsia; 2000 May; 41(5):628-30. PubMed ID: 10802771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of West syndrome with vigabatrin: clinical and electroencephalographic evaluation of 13 patients].
    Henriques-Souza AM; Ataide Junior L; Laurentino SG
    Arq Neuropsiquiatr; 2007 Mar; 65(1):144-49. PubMed ID: 17420838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerability of vigabatrin in West syndrome].
    Moraes MH; Montenegro MA; Franzon RC; Avila JO; Guerreiro MM
    Arq Neuropsiquiatr; 2005 Jun; 63(2B):469-73. PubMed ID: 16059600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.
    Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW
    Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome.
    Reyes Valenzuela G; Crespo A; Princich J; Fassulo L; Semprino M; Gallo A; Rugilo C; Pociecha J; Calvo A; Caraballo RH
    Epilepsy Behav; 2022 Apr; 129():108606. PubMed ID: 35180571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
    Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
    No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
    Granström ML; Gaily E; Liukkonen E
    Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
    Westall CA; Wright T; Cortese F; Kumarappah A; Snead OC; Buncic JR
    Neurology; 2014 Dec; 83(24):2262-8. PubMed ID: 25381295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin therapy in infantile spasms.
    Kankirawatana P; Raksadawan N; Balangkura K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in the treatment of infantile spasms.
    Koo B
    Pediatr Neurol; 1999 Feb; 20(2):106-10. PubMed ID: 10082337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential for vigabatrin-induced intramyelinic edema in humans.
    Cohen JA; Fisher RS; Brigell MG; Peyster RG; Sze G
    Epilepsia; 2000 Feb; 41(2):148-57. PubMed ID: 10691111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN; Penney S; Buckley DJ
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
    Appleton RE; Peters AC; Mumford JP; Shaw DE
    Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature.
    Bhalla S; Skjei K
    Epilepsia; 2020 Oct; 61(10):e159-e164. PubMed ID: 32944947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis.
    Biswas A; Yossofzai O; Vincent A; Go C; Widjaja E
    Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.